DoD FY15 Peer Reviewed Alzheimer’s Convergence Science Research Award
The summary for the DoD FY15 Peer Reviewed Alzheimer’s Convergence Science Research Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD FY15 Peer Reviewed Alzheimer’s Convergence Science Research Award: The Peer Reviewed Alzheimer’s Research Program (PRARP) Convergence Science Research Award (CSRA) mechanism was first offered in FY12. Since then, 92 CSRA applications have been received, and 22 have been recommended for funding.
The intent of the FY15 CSRA is to support efforts to generate research resources, tools, or novel research efforts for researchers and/or practitioners in health sciences related to the PRARP’s mission. The research impact will benefit the military, Veteran, and civilian communities.
The CSRA is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the PRARP’s mission. However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and AD research. Preliminary data, while not required, is encouraged.
FY15 CSRA Overarching Challenges: This CSRA funding opportunity requires applications to address one or more of the following Overarching Challenges:
Paucity of Research Resources: The paucity of research resources to examine the interrelationship between TBI and subsequent AD for the military and Veteran communities.
Paucity of Clinical Studies: The paucity of clinical or epidemiological studies to examine the interrelationship between TBI and subsequent AD for the military and Veteran communities.
Diagnostic Technologies, Tests, or Devices: The need for technologies, tests, or devices to detect the progression to AD subsequent to TBI.
FY15 CSRA Focus Areas: In addition to addressing one or more of the specified FY15 Overarching Challenges, applications should also address at least one of the following FY15 Focus Areas in support of the FY15 Overarching Challenges. An application that proposes research outside of the FY15 Focus Areas is acceptable, as long as the applicant provides a strong rationale.
Genomics/Proteomics/Bioinformatics: Studies or technologies (e.g., genetic, proteomic, and epigenetic strategies) intended to characterize neurological change(s) associated with TBI and subsequent AD. In addition, relevant technologies or tests may be considered under this focus area.
Pathology of Tau: Novel research and technologies dedicated to unraveling the basic pathological mechanisms of Tau associated with TBI and AD.
Roles of Non-Neuronal Cells in TBI/AD Pathogenesis: Technologies, tests, studies, or devices that will examine the roles of astrocytes (or other non-neuronal cells) in AD neurodegeneration due to TBI.
Novel Target Identification: Basic research (non-human) directly leading to the identification of new targets for the development of existing or new investigational medicines, drugs, or agents.
The following is specifically discouraged under the FY15 PRARP:
Pharmacologic Interventions: Clinical or Basic research requiring investigational or U.S. Food and Drug Administration (FDA)-approved drugs or medicines.
The intent of the FY15 CSRA is to support efforts to generate research resources, tools, or novel research efforts for researchers and/or practitioners in health sciences related to the PRARP’s mission. The research impact will benefit the military, Veteran, and civilian communities.
The CSRA is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the PRARP’s mission. However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and AD research. Preliminary data, while not required, is encouraged.
FY15 CSRA Overarching Challenges: This CSRA funding opportunity requires applications to address one or more of the following Overarching Challenges:
Paucity of Research Resources: The paucity of research resources to examine the interrelationship between TBI and subsequent AD for the military and Veteran communities.
Paucity of Clinical Studies: The paucity of clinical or epidemiological studies to examine the interrelationship between TBI and subsequent AD for the military and Veteran communities.
Diagnostic Technologies, Tests, or Devices: The need for technologies, tests, or devices to detect the progression to AD subsequent to TBI.
FY15 CSRA Focus Areas: In addition to addressing one or more of the specified FY15 Overarching Challenges, applications should also address at least one of the following FY15 Focus Areas in support of the FY15 Overarching Challenges. An application that proposes research outside of the FY15 Focus Areas is acceptable, as long as the applicant provides a strong rationale.
Genomics/Proteomics/Bioinformatics: Studies or technologies (e.g., genetic, proteomic, and epigenetic strategies) intended to characterize neurological change(s) associated with TBI and subsequent AD. In addition, relevant technologies or tests may be considered under this focus area.
Pathology of Tau: Novel research and technologies dedicated to unraveling the basic pathological mechanisms of Tau associated with TBI and AD.
Roles of Non-Neuronal Cells in TBI/AD Pathogenesis: Technologies, tests, studies, or devices that will examine the roles of astrocytes (or other non-neuronal cells) in AD neurodegeneration due to TBI.
Novel Target Identification: Basic research (non-human) directly leading to the identification of new targets for the development of existing or new investigational medicines, drugs, or agents.
The following is specifically discouraged under the FY15 PRARP:
Pharmacologic Interventions: Clinical or Basic research requiring investigational or U.S. Food and Drug Administration (FDA)-approved drugs or medicines.
Federal Grant Title: | DoD FY15 Peer Reviewed Alzheimer’s Convergence Science Research Award |
Federal Agency Name: | Dept of the Army USAMRAA |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-15-PRARP-CSRA |
Type of Funding: | Cooperative Agreement, Grant |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Military Medical Research and Development |
Current Application Deadline: | Nov 25, 2015 |
Original Application Deadline: | Nov 25, 2015 |
Posted Date: | Jul 20, 2015 |
Creation Date: | Jul 20, 2015 |
Archive Date: | Dec 25, 2015 |
Total Program Funding: | $2,800,000 |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk
Dept. of the Army -- USAMRAA 301-619-7144 - Similar Government Grants
- • DoD Peer Reviewed Medical, Impact Award
- • DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
- • DoD Peer Reviewed Medical, Discovery Award
- • DoD Peer Reviewed Medical, Technology/Therapeutic Development Award
- • DoD Peer Reviewed Medical, Clinical Trial Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • Spinal Cord Injury Research Program Clinical Translation Research Award
- • Spinal Cord Injury Research Program Clinical Trial Award
- • DoD Hearing Restoration Focused Research Award
- • DOD Spinal Cord Injury Research Program Translational Research Award
- • DoD Autism, Clinical Trial Award